tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Apnimed data brings competitive threat to ResMed, says RBC Capital
PremiumThe FlyApnimed data brings competitive threat to ResMed, says RBC Capital
2M ago
Resmed’s Growth Potential Highlighted by Promising Trial Results and Future Opportunities
Premium
Ratings
Resmed’s Growth Potential Highlighted by Promising Trial Results and Future Opportunities
2M ago
Buy Rating for Resmed: Positive Phase 3 Trial Results and Market Conditions Boost AD109’s Appeal
Premium
Ratings
Buy Rating for Resmed: Positive Phase 3 Trial Results and Market Conditions Boost AD109’s Appeal
2M ago
Early notable gainers among liquid option names on April 24th
PremiumThe FlyEarly notable gainers among liquid option names on April 24th
3M ago
ResMed price target lowered to $285 from $290 at UBS
Premium
The Fly
ResMed price target lowered to $285 from $290 at UBS
3M ago
ResMed price target lowered to $250 from $265 at Mizuho
Premium
The Fly
ResMed price target lowered to $250 from $265 at Mizuho
3M ago
Resmed’s Strong Q3 Performance and Strategic Positioning Justify Buy Rating
PremiumRatingsResmed’s Strong Q3 Performance and Strategic Positioning Justify Buy Rating
3M ago
Resmed Inc. Reports Strong Q3 2025 Earnings
Premium
Company Announcements
Resmed Inc. Reports Strong Q3 2025 Earnings
3M ago
Closing Bell Movers: Robert Half down 15% after earnings miss
Premium
The Fly
Closing Bell Movers: Robert Half down 15% after earnings miss
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100